Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction

Biomaterials
Inthirai SomasuntharamMichael E Davis

Abstract

In this study, we used deoxyribozyme (DNAzyme) functionalized gold nanoparticles (AuNPs) to catalytically silence tumor necrosis factor-α (TNF-α) in vivo as a potential therapeutic for myocardial infarction (MI). Using primary macrophages as a model, we demonstrated 50% knockdown of TNF-α, which was not attainable using Lipofectamine-based approaches. Local injection of DNAzyme conjugated to gold particles (AuNPs) in the rat myocardium yielded TNF-α knockdown efficiencies of 50%, which resulted in significant anti-inflammatory effects and improvement in acute cardiac function following MI. Our results represent the first example showing the use of DNAzyme AuNP conjugates in vivo for viable delivery and gene regulation. This is significant as TNF-α is a multibillion dollar drug target implicated in many inflammatory-mediated disorders, thus underscoring the potential impact of DNAzyme-conjugated AuNPs.

References

Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T GulickG F Schreiner
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·K M KurrelmeyerD L Mann
Dec 18, 2001·Cardiovascular Research·Nikolaos G FrangogiannisMark L Entman
Feb 9, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Fenwei WangBarry F Uretsky
Nov 7, 2002·International Journal of Cardiology·Stefan D Anker, Andrew J S Coats
Jun 26, 2004·Circulation Research·Min NianPeter Liu
Apr 4, 2006·Cardiovascular Research·Aleksey V Zima, Lothar A Blatter
May 20, 2006·Science·Nathaniel L RosiChad A Mirkin
Jul 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hongtao LvJie Yan
Jul 18, 2006·Current Medicinal Chemistry·Nikolaos G Frangogiannis
Dec 15, 2006·Analytical Chemistry·Sarah J HurstChad A Mirkin
Nov 14, 2007·Nano Letters·David A GiljohannChad A Mirkin
Nov 21, 2007·The Journal of Experimental Medicine·Matthias NahrendorfMikael J Pittet
Dec 7, 2007·The New England Journal of Medicine·Radhakrishnan Ramaraj
Apr 1, 2008·Pharmaceutical Research·Julie A ChampionSamir Mitragotri
Feb 21, 2009·Journal of Cellular and Molecular Medicine·C TroidlA Elsässer
Jun 10, 2010·Circulation·Matthias NahrendorfFilip K Swirski
Jun 24, 2010·Heart Failure Reviews·Petra KleinbongardGerd Heusch
Dec 1, 2010·Nature Reviews. Genetics·Benjamin Czech, Gregory J Hannon
Jan 10, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tibor KempfKai C Wollert
Jan 11, 2012·Journal of the American Chemical Society·Joshua I CutlerChad A Mirkin
Apr 28, 2012·Clinical and Vaccine Immunology : CVI·Dionysios C WatsonGeorge Panos
Jul 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Dan ZhengAmy S Paller
Apr 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Chung Hang J ChoiChad A Mirkin
Nov 1, 2013·Science Translational Medicine·Samuel A JensenAlexander H Stegh
Dec 18, 2013·Free Radical Biology & Medicine·Stefan R MazurekAleksey V Zima
Dec 20, 2013·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 22, 2014·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
May 21, 2014·Journal of the American Chemical Society·Xiaochen A WuChad A Mirkin
Aug 31, 2014·Advanced Drug Delivery Reviews·Conn L HastingsGarry P Duffy
Apr 7, 2015·The Journal of Allergy and Clinical Immunology·Ursula HomburgHolger Garn

❮ Previous
Next ❯

Citations

Jun 3, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Levon M Khachigian
Jun 2, 2017·Future Cardiology·Sang-Bing OngDerek J Hausenloy
Feb 7, 2019·Advanced Healthcare Materials·JingJing ZhangYi Lu
Jul 17, 2020·Frontiers in Bioengineering and Biotechnology·Chengming FanWuqiang Zhu
Sep 28, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yuanyuan YouTianfeng Chen
Dec 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Hamed AmaniOmid Akhavan
Aug 23, 2020·International Journal of Molecular Sciences·Saltanat SmagulArman Saparov
Feb 15, 2019·Cancer Research·Levon M Khachigian
May 14, 2021·Trends in Biotechnology·Jiahui Zhang, Khalid Salaita
Apr 7, 2021·Angewandte Chemie·Congzhi LiuYuliang Zhao
Jun 5, 2021·Advanced Healthcare Materials·Luyao ShenYonggang Ke
May 20, 2021·Biomaterials·Nadim AhamadRinti Banerjee
Aug 7, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Congcong LinLiang Ouyang
Dec 16, 2020·ACS Biomaterials Science & Engineering·Suliman KhanMojtaba Falahati
Nov 21, 2017·ACS Chemical Biology·Jessica R PetreeKhalid Salaita
Aug 18, 2020·ACS Applied Materials & Interfaces·Jiahui ZhangKhalid Salaita
Aug 28, 2021·Micromachines·Arsalan Ul HaqFabio De Matteis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.